Compare UTMD & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UTMD | QSI |
|---|---|---|
| Founded | 1978 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.4M | 165.3M |
| IPO Year | 1994 | N/A |
| Metric | UTMD | QSI |
|---|---|---|
| Price | $62.87 | $0.75 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 10.1K | ★ 3.1M |
| Earning Date | 04-28-2026 | 03-03-2026 |
| Dividend Yield | ★ 2.00% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.48 | N/A |
| Revenue | ★ $38,520,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $618.07 |
| P/E Ratio | $17.81 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $51.27 | $0.73 |
| 52 Week High | $68.71 | $3.10 |
| Indicator | UTMD | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 46.29 | 35.03 |
| Support Level | $62.22 | N/A |
| Resistance Level | $64.21 | $1.11 |
| Average True Range (ATR) | 2.11 | 0.05 |
| MACD | -0.22 | -0.01 |
| Stochastic Oscillator | 31.61 | 12.01 |
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.